Yale University

Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US.

TitlePrioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US.
Publication TypeJournal Article
Year of Publication2015
AuthorsPei, Pamela P., Milton C. Weinstein, Cynthia X. Li, Michael D. Hughes, David A. Paltiel, Taige Hou, Robert A. Parker, Melanie R. Gaynes, Paul E. Sax, Kenneth A. Freedberg, Bruce R. Schackman, and Rochelle P. Walensky
JournalHIV clinical trials
Pagination1945577115Y0000000009
Date Published2015 Sep 14
ISSN1528-4336
AbstractValue of Information (VOI) analysis examines whether to acquire information before making a decision. We introduced VOI to the HIV audience, using the example of generic antiretroviral therapy (ART) in the US.
Alternate JournalHIV Clin Trials

External Links